The latest proposed bone regenerative therapy is a paint-like substance that coats implants or other devices to promote bone regrowth. It’s designed for use in treating combat injuries and lower back pain, among other issues. After about $9 million in grants from the Departments of Defense and Veterans Affairs, the substance, called AMP2, made by the company Theradaptive, is moving onto the next trial phase, a step ahead of testing on humans. Creator Luis Alvarez, a retired Army lieutenant colonel who served a year in Iraq, said coating an implant is much better than the current, more dangerous therapy for bone regrowth. Read more on Military.com.
Military Report: The Hot List
Most Popular Benefits Articles
As of March 24, National Guard personnel officials completed transitioning 331,000 members onto the IPPS-A.
This student veteran package would ensure veterans aren't charged for not completing their program because of closures.
Vietnam-era and other pre-9/11 vets are closer to accessing a program designed to pay family support for in-home care.
So far, so good. Veterans can now access their local military base to take advantage of benefits there. Here's how to do it.
The list is included in a 61-page report to Congress delivered Wednesday.